These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25005765)

  • 1. Noninvasive Transcutaneous Monitoring in Long-Term Follow-Up of Patients With Thromboangiitis Obliterans Treated With Intravenous Iloprost.
    Melillo E; Grigoratos C; Sanctis FD; Spontoni P; Nuti M; Dell'Omodarme M; Ferrari M; Balbarini A
    Angiology; 2015 Jul; 66(6):531-8. PubMed ID: 25005765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative treatment of patients with thromboangiitis obliterans or cannabis-associated arteritis presenting with critical lower limb ischaemia.
    Galyfos G; Kerasidis S; Kastrisios G; Giannakakis S; Sachmpazidis I; Anastasiadou C; Geropapas G; Papapetrou A; Papacharalampous G; Maltezos C
    Vasa; 2017 Oct; 46(6):471-475. PubMed ID: 28753096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is transcutaneous oxygen and carbon dioxide monitoring indispensable in short- and long-term therapeutic management of non-reconstructable lower critical limb ischemia?
    Melillo E; Nuti M; Pedrinelli R; Buttitta F; Balbarini A
    Minerva Cardioangiol; 2006 Aug; 54(4):481-98. PubMed ID: 17016419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of intravenous ilomedin infusion and smoking cessation in the treatment of acutely symptomatic Buerger disease.
    Spanos K; Georgiou E; Saleptsis V; Athanasoulas A; Sakkas L; Giannoukas AD
    Angiology; 2015 Feb; 66(2):114-7. PubMed ID: 24366824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy of intravenous iloprost (Ilomedin®) in salvage of the only extremity in a patient with thrombangiitis obliterans].
    Gaĭsin IR; Bagautdinova ZR; Trukhina AA; Burlaeva NA; Gibadullina LR; Timonin DV; Smirnov IA; maksimov NI
    Angiol Sosud Khir; 2014; 20(2):150-6. PubMed ID: 24961337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of duplex ultrasonography in the treatment of thromboangiitis obliterans with iloprost.
    Noël B; Panizzon RG
    Dermatology; 2004; 208(3):238-40. PubMed ID: 15118378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compartment syndrome as a rare complication of iloprost infusion for peripheral vascular disease.
    Thomas GP; Kadam S; Mohammed M; Andrews BT
    Ann Vasc Surg; 2011 May; 25(4):555.e11-2. PubMed ID: 21549925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral iloprost in the treatment of thromboangiitis obliterans (Buerger's disease): a double-blind, randomised, placebo-controlled trial. The European TAO Study Group.
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):300-7. PubMed ID: 9610341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reproducibility of transcutaneous oximetry and laser Doppler flowmetry in facial skin and gingival tissue.
    Svalestad J; Hellem S; Vaagbø G; Irgens A; Thorsen E
    Microvasc Res; 2010 Jan; 79(1):29-33. PubMed ID: 19837098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regarding the quantification of peripheral microcirculation--Comparing responses evoked in the in vivo human lower limb by postural changes, suprasystolic occlusion and oxygen breathing.
    Silva H; Ferreira H; Bujan MJ; Rodrigues LM
    Microvasc Res; 2015 May; 99():110-7. PubMed ID: 25872021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ilomedin (Iloprost) and Buerger disease].
    Benthin NP
    Ugeskr Laeger; 1995 Sep; 157(36):4946-7. PubMed ID: 7545838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman.
    Lopalco G; Iannone F; Rigante D; Vitale A; Mancini ME; Covelli M; Lapadula G; Cantarini L
    Reumatismo; 2015 Jun; 67(1):17-20. PubMed ID: 26150270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of thromboangiitis obliterans (Buerger's disease) with high-potency vasodilators.
    Jiménez-Gallo D; Albarrán-Planelles C; Arjona-Aguilera C; Blanco-Sánchez G; Rodríguez-Mateos ME; Linares-Barrios M
    Dermatol Ther; 2015; 28(3):135-9. PubMed ID: 25649782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iloprost: new indication. Not adequately assessed.
    Prescrire Int; 1999 Apr; 8(40):49-50. PubMed ID: 10848061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and tolerability of oral iloprost in thromboangiitis obliterans patients.
    Hildebrand M
    Eur J Clin Pharmacol; 1997; 53(1):51-6. PubMed ID: 9349930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI; Edvinsson ML; Angus Deveber G
    Int Angiol; 2003 Jun; 22(2):141-7. PubMed ID: 12865879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the management of Buerger's disease.
    Bozkurt AK; Köksal C; Demirbas MY; Erdoğan A; Rahman A; Demirkiliç U; Ustünsoy H; Metin G; Yillik L; Onol H; Cinar B; Karaçelik M; Erdinç I; Bolcal C; Sayin AG;
    Int Angiol; 2006 Jun; 25(2):162-8. PubMed ID: 16763533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboangiitis obliterans successfully treated with phosphodiesterase type 5 inhibitors.
    Abeles AM; Nicolescu M; Pinchover Z; Abeles M
    Vascular; 2014 Aug; 22(4):313-6. PubMed ID: 24000082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outpatient treatment of severe peripheral ischemia with intravenous intermittent low-dose iloprost. An open pilot study.
    Banyai S; Jenelten R; Wagner S; Allmann J; Banyai M; Koppensteiner R
    Int Angiol; 2002 Mar; 21(1):36-43. PubMed ID: 11941272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of alpha-trinositol on peripheral circulation in diabetic patients with critical limb ischaemia. A pilot study using laser Doppler fluxmetry, transcutaneous oxygen tension measurements and dynamic capillaroscopy.
    Nilsson L; Apelqvist J; Edvinsson L
    Eur J Vasc Endovasc Surg; 1998 Apr; 15(4):331-6. PubMed ID: 9610346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.